National Research Corporation (NASDAQ:NRC – Get Free Report) crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $16.90 and traded as high as $19.22. National Research shares last traded at $18.67, with a volume of 78,454 shares traded.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings lowered National Research from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, March 6th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of “Sell”.
View Our Latest Research Report on NRC
National Research Stock Down 2.7%
National Research (NASDAQ:NRC – Get Free Report) last released its quarterly earnings results on Tuesday, April 28th. The company reported $0.21 EPS for the quarter. The company had revenue of $34.80 million for the quarter. National Research had a return on equity of 122.73% and a net margin of 6.52%.
National Research Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, July 10th. Shareholders of record on Friday, June 26th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $0.64 annualized dividend and a yield of 3.4%. National Research’s payout ratio is 164.10%.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in the company. Hotchkis & Wiley Capital Management LLC increased its position in National Research by 7.9% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 292,400 shares of the company’s stock worth $3,737,000 after buying an additional 21,450 shares during the period. Bank of New York Mellon Corp increased its position in National Research by 4.0% during the first quarter. Bank of New York Mellon Corp now owns 250,707 shares of the company’s stock worth $4,257,000 after buying an additional 9,730 shares during the period. Heartland Advisors Inc. increased its position in National Research by 374.3% during the first quarter. Heartland Advisors Inc. now owns 237,147 shares of the company’s stock worth $4,027,000 after buying an additional 187,147 shares during the period. AQR Capital Management LLC increased its position in National Research by 86.2% during the second quarter. AQR Capital Management LLC now owns 201,396 shares of the company’s stock worth $3,383,000 after buying an additional 93,262 shares during the period. Finally, Willis Investment Counsel increased its position in National Research by 1.6% during the fourth quarter. Willis Investment Counsel now owns 183,226 shares of the company’s stock worth $3,439,000 after buying an additional 2,920 shares during the period. Institutional investors and hedge funds own 47.26% of the company’s stock.
National Research Company Profile
National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.
Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.
Featured Stories
- Five stocks we like better than National Research
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.
